- Novartis/Sandoz make history with 1st US biosimilar Zarxio
- With $36bn from Teva, what should Allergan buy next?
- US Capitol Capsule: Obama closer on trade, but will biopharma get its way?
- Samsung Bioepis files second biosimilar in Europe
- Executive profile: the life and career of Genzyme CEO David Meeker
- Profile: Lupin siblings on dinner table chats and not emulating Teva